As a true third party control, assay drift is detected, monitored and managed, helping to ensure accurate and reliable results. This dedicated, positive run control is designed for use in monitoring the performance of molecular assays used in the detection of Influenza A, Influenza B,Respiratory Syncytial Virus A and SARS-CoV-2.
- Target Pathogen - Influenza A (H1N1), Influenza B (Victoria), RSV A, Coronavirus (SARS-CoV-2)
- Target - Whole Pathogen
- Matrix - Transport Medium
- Format - Liquid Frozen
Features & Benefits:
Whole Pathogen - Contains the entire viral genome therefore compatible with the majority of commercial and in-house assays.
Full Process Control – Effectively monitors the performance of the entire testing process from extraction to amplification and detection.
Highly Characterised - Quantified by digital PCR ensuring batch to batch reproducibility.
True Third Party – An independent, unbiased assessment of assay performance is ensured in line with regulatory requirements.
Superior Manufacturing - Manufactured to ISO 13485:2016 standard and traceable to an internal reference preparation ensuring metrological traceability of test results.
Liquid for Ease-of-use - Conveniently supplied in a liquid frozen format meaning there is no additional preparation or handling required.